Immunex`s Biologics Enbrel Receives Suppl Approval in US

Immunex`s Biologics Enbrel Receives Suppl Approval in US
FDA
18 Jun 2025
Share Share
Xiromed`s Generics Selenious Receives Tentative Approval in US

Xiromed`s Generics Selenious Receives Tentative Approval in US
FDA
12 Jun 2025
Share Share
Nexus`s Generics Minocycline Receives Tentative Approval in US

Nexus`s Generics Minocycline Receives Tentative Approval in US
FDA
12 Jun 2025
Share Share

Enforcement Report - Week of June 18, 2025

Enforcement Report - Week of June 18, 2025
FDA
18 Jun 2025
Share Share
Enforcement Report - Week of June 11, 2025

Enforcement Report - Week of June 11, 2025
FDA
11 Jun 2025
Share Share
Amish Origins Recieves Management Warning Letter

Amish Origins Recieves Management Warning Letter
FDA
10 Jun 2025
Share Share

Dupixent US Approval For Bullous Pemphigoid Treatment

Dupixent US Approval For Bullous Pemphigoid Treatment
PRESS RELEASE
21 Jun 2025
Share Share
Roche Combo Lunsumio & Polivy Doubles Remission in LBCL

Roche Combo Lunsumio & Polivy Doubles Remission in LBCL

PRESS RELEASE
21 Jun 2025
Share Share
Novo Nordisk`s experimental drug results in up to 24% weight loss

Novo Nordisk`s experimental drug results in up to 24% weight loss
PRESS RELEASE
21 Jun 2025
Share Share
Trump aid cuts deal a blow to HIV prevention in Africa

Trump aid cuts deal a blow to HIV prevention in Africa
REUTERS
21 Jun 2025
Share Share
Arialys Presents Promising Data for IgG1 Antibody Treatment

Arialys Presents Promising Data for IgG1 Antibody Treatment
FIERCE BIOTECH
21 Jun 2025
Share Share
Tweaked ACIP vaccine agenda raises industry watcher concerns

Tweaked ACIP vaccine agenda raises industry watcher concerns
FIERCE PHARMA
21 Jun 2025
Share Share
EU regulator backs Conditional Authorisation for Madrigal`s Drug

EU regulator backs Conditional Authorisation for Madrigal`s Drug
REUTERS
21 Jun 2025
Share Share
CHMP Recommends Darolutamide for Advanced Prostate Cancer

CHMP Recommends Darolutamide for Advanced Prostate Cancer
PRESS RELEASE
21 Jun 2025
Share Share
Actuate Shares Phase 2 Pancreatic Cancer Trial Data

Actuate Shares Phase 2 Pancreatic Cancer Trial Data
GLOBENEWSWIRE
20 Jun 2025
Share Share
Scholar Rock`s Drug Helps Zepbound Patients Retain More Muscle

Scholar Rock`s Drug Helps Zepbound Patients Retain More Muscle
REUTERS
20 Jun 2025
Share Share